Genedrive (LON:GDR), an innovative diagnostic company, focuses on the development and commercialization of a novel, point-of-care diagnostic system, also called Genedrive® (in line with Company's policy, "genedrive" refers to the business, whereas "Genedrive®" indicates the diagnostic product).
Genedrive (LON:GDR) is the first firm to launch a decentralized Hepatitis C diagnostic kit, entering a large market at a time when new curative therapies for this severe disease are transforming opportunities for testing and treatment. We also note that the Company's diagnostic technology has a wide range of potential applications, ranging from the diagnosis of many other infectious diseases, to biohazard detection and applications in industrial settings (e.g. aquaculture).
